Turkish Version of the Brief-BESTest Scale

2020-02-17 18:20:43 | BioPortfolio


The aim of this study is to investigate the validity and reliability of the Turkish version of the brief-BESTest (short BESTest) scale in stroke patients.


Brief Balance Evaluation Systems Test (Brief-BESTest) is a short version of the Balance evaluation systems test (BESTest). Balance assessment systems test (BESTest) The balance assessment systems test developed by Horak consists of 6 sub-sections that evaluate the systems related to balance; 1) biomechanical limitations, 2) stability limit, 3) postural responses, 4) intuitive postural adjustments, 5) sensory orientation and 6) walking. It consists of 36 tests in total. Each question is rated between 0-3. The highest score that can be obtained is 108. Low test scores show that the balance is disturbed. BESTest has been found to be reliable among raters evaluating a cohort of individuals with and without various neurological diagnoses. In studies conducted, it was stated that BESTest is reliable when compared to other scales evaluating balance.

The necessary permissions have been obtained from the authors for Short BESTest, whose validity and reliability features will be tested, and the translation process to Turkish has been completed and the survey has been finalized. The basis for the use of special tools such as the scale is to prove the usability of the tool in the sample group to which it will be applied. The first step for this is the translation stage from the original language to the other language.

At the stage of translation into Turkish, two experts who knew a good level of English translated the questionnaire from English into Turkish. These translations have been translated back into Turkish by two native speakers of English and distant medical subjects. In addition, these translations were re-examined by the researchers and turned into a single form. This form was sent to five specialists in the field, checking the content and compliance with Turkish was evaluated. With the opinion of experts, the scale was finalized.

The study will include individuals over 40 years of age who have been diagnosed with an ischemic or hemorhagic stroke, who applied to the Kırıkkale University Faculty of Medicine Physical Therapy and Rehabilitation Hospital.

Study Design


Stroke Patients


Kırıkkale University




Kırıkkale University

Results (where available)

View Results


Published on BioPortfolio: 2020-02-17T18:20:43-0500

Clinical Trials [2101 Associated Clinical Trials listed on BioPortfolio]

Atrial Cardiomyopathy in Patients With Stroke of Undetected Mechanism

The goal of this study is to evaluate left atrial structural and functional abnormalities in stroke of likely cardio-embolic origin and atherosclerotic stroke with cardiac MRI.

Hypoalbuminemia in Mild Acute Stroke and Cognitive Impariment Post-stroke

This registration enrolled patients with acute ischemic stroke within 72 hours after stroke ictus. Patients was identified as first-ever stroke based on past medical histrory. Admission CT...

The Effectiveness of Multimodal Educational Intervention to Improve Adherence to Treatment Regimens in Older Stroke Patients: A Randomised Trial

Stroke is a major cause of morbidity and mortality, especially in low and middle income countries including Iran. Patients with recent stroke or TIA are at high risk for new vascular event...

Dose Milnacipran Prevent Depressive Symptoms in Patients With Acute Stroke?

Depression is one of the important psychiatric sequelae after stroke. The prevalence of post stroke depression (PSD) is approximately 20-40%. Depression comorbid with stroke has been foun...

Post-stroke Pathway: Analysis and Link With One Year Sequelae in a French Cohort of Stroke Patients

The link between post-stroke pathways and patient sequelae have not yet been clearly defined. The main purpose is to identify the post-stroke life pathways components associated with sequa...

PubMed Articles [25499 Associated PubMed Articles listed on BioPortfolio]

Cancer-Related Stroke: An Emerging Subtype of Ischemic Stroke with Unique Pathomechanisms.

Systemic cancer and ischemic stroke are common conditions and two of the most frequent causes of death among the elderly. The association between cancer and stroke has been reported worldwide. Stroke ...

Direct Admission vs. Secondary Transfer to a Comprehensive Stroke Center for Thrombectomy : Retrospective Analysis of a Regional Stroke Registry with 2797 Patients.

This study aimed at comparing short-term clinical outcome after thrombectomy in patients directly admitted (DA) to a comprehensive stroke center with patients secondarily transferred (ST) from a pri...

Rare causes of stroke-a frequent stroke etiology.

As a whole, rare stroke causes represent a frequent stroke etiology. Since rare stroke causes affect primarily young patients, early diagnosis and treatment are of high socioeconomic relevance. In our...

Similar thrombolysis outcomes in acute stroke patients with and without atrial fibrillation if pre-stroke CHA2DS2-VASc score is low: A retrospective study.

The prognosis of acute ischemic stroke patients treated with intravenous (IV) recombinant tissue plasminogen activator (rtPA) is poorer in patients with atrial fibrillation (AF) than patients without ...

A DS Score to Predict the Risk of Stroke-Associated Pneumonia in Acute Stroke: An Indian Perspective.

 Stroke-associated pneumonia (SAP) is an important cause of poststroke morbidity and mortality. Several clinical risk scores predict the risk of SAP. In this study, we used the A DS score (age, at...

Medical and Biotech [MESH] Definitions

Restoration of functions to the maximum degree possible in a person or persons suffering from a stroke.

A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM. It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME.

Stroke caused by lacunar infarction or other small vessel diseases of the brain. It features hemiparesis (see PARESIS), hemisensory, or hemisensory motor loss.

A THROMBIN inhibitor which acts by binding and blocking thrombogenic activity and the prevention of thrombus formation. It is used to reduce the risk of stroke and systemic EMBOLISM in patients with nonvalvular atrial fibrillation.

A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)

More From BioPortfolio on "Turkish Version of the Brief-BESTest Scale"

Quick Search

Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Searches Linking to this Trial